世界卫生组织东地中海区域国家免疫技术咨询小组(NITAGs):塑造免疫政策的十年,2010-2021年
该研究从WHO/UNICEF联合报告表和WHO免疫门户提取数据,描述2010-2021年东地中海区域22国NITAGs的建立与功能趋势及免疫政策实施情况。2013年所有22国均设有NITAG,2021年仅20国活跃;满足六项NITAG流程指标的国家数从2010年7个增至2019年14个,2021年降至12个。2021年功能性NITAG比例随收入水平下降:高收入国家83%、中等收入国家55%、低收入国家20%。2010-2021年所有22国共实施103项新疫苗引入、31项疫苗转换和28项免疫程序变更。
要点
- 2013年东地中海区域全部22国均设有NITAG,但2021年仅20国NITAG仍活跃。
- 满足六项NITAG流程指标的国家数从2010年7个增至2019年14个,2021年降至12个。
- 2021年功能性NITAG比例随收入水平下降:高收入国家83%、中等收入国家55%、低收入国家20%。
核心结论
- 尽管各国已建立NITAG并正在提出建议,但其功能随收入水平下降。
- 政府应继续投资于NITAG,包括加强流程并确保所提建议基于证据到决策框架。
研究设计与样本
- 从WHO/UNICEF联合报告表提取信息,并从WHO免疫门户提取已实施的免疫政策决定,描述2010-2021年东地中海区域NITAGs的建立与功能趋势及实施的免疫政策。
主要发现
- 2013年全部22个东地中海区域国家均设有NITAG,但2021年仅20个仍活跃。
- 满足六项NITAG流程指标的国家数从2010年7个增至2019年14个,2021年降至12个。
- 2021年功能性NITAG比例随收入水平下降:高收入国家83%、中等收入国家55%、低收入国家20%。
- 2010-2021年所有22国共实施103项新疫苗引入、31项疫苗转换和28项免疫程序变更,不论收入组别。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO), little is known on National Immunization Technical Advisory Groups' (NITAGs) outputs, including recommendations and their outcomes. We abstracted information from the WHO/UNICEF joint reporting forms and extracted implemented immunization policy decisions from the WHO immunization portal. We describe trends in establishments and functionality of NITAGs and immunization policies implemented in EMR from 2010 to 2021. In 2013, all 22 EMR countries had a NITAG, although only 20 remained active in 2021. The number of countries meeting six NITAG process indicators increased from 7 in 2010, to 14 in 2019, then reduced to 12 in 2021. In 2021, the proportion of countries with a functional NITAG decreased with income level, from 83% in high-income countries, to 55% in middle-income countries and 20% in low-income countries. From 2010 to 2021, there were 103 new vaccine introductions, 31 vaccine switches, and 28 schedule changes implemented across all 22 countries, irrespective of income groups. While NITAGs are established and making recommendations in countries, their functionality decreases with income level. Governments should continue to invest in NITAGs, including on strengthening processes and ensuring that recommendations made are based on evidence to decision frameworks.
引用
- Etapelong Sume G, Quamrul H, Md S, et al. National immunization technical advisory groups (NITAGs) in the WHO Eastern Mediterranean Region (EMR): A decade of shaping immunization policies, 2010-2021. Vaccine. 2023. PMID: 38143199. doi:10.1016/j.vaccine.2023.12.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。